Ovarian CarcinosarcomaSymptoms, Doctors, Treatments, Advances & More
Learn About Ovarian Carcinosarcoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Main Campus
Peter Rose is a Surgical Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 49 years. Dr. Rose is rated as an Elite provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Salpingo-Oophorectomy, and Hernia Surgery. Dr. Rose is board certified in American Board Of Obstetrics And Gynecology, 1990.
Northwell Health Physician Partners Gynecologic Oncology At New Hyde Park
Joan Tymon is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Tymon is rated as an Elite provider by MediFind in the treatment of Ovarian Carcinosarcoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tymon is board certified in American Board Of Obstetrics & Gynecology.
Aurora Gynecologic Oncology
Scott Kamelle is an Oncologist practicing medicine in West Allis, Wisconsin. Dr. Kamelle is rated as a Distinguished provider by MediFind in the treatment of Ovarian Carcinosarcoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ureteroscopy, and Bladder Reconstruction. Dr. Kamelle is board certified in American Board Of Obstetrics & Gynecology, Gynecologic Oncology.
Summary: This phase I/II trial tests the safety, side effects, best dose, and effectiveness of multi-epitope folate receptor alpha-loaded dendritic cell vaccine (FRalphaDC) with pembrolizumab in treating patients with ovarian, fallopian tube, or primary peritoneal cancer (collectively known as ovarian cancer) that that has come back (after a period of improvement) (recurrent). Ovarian cancer is the most le...
Summary: This phase II trial studies the effect of APL-2 when given in combination with either pembrolizumab or pembrolizumab and bevacizumab compared with bevacizumab alone in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent) and a buildup of fluid and cancer cells (malignant effusion). APL-2 may limit tumor progression, decrease malignant effusion...